STONKWHISPER
← Back to Intel
Insider ActivityNKTR

Zalevsky Jonathan, Chief R&D Officer at NEKTAR THERAPEUTICS, sold $336K of NKTR

Updated Jun 19, 2026
Zalevsky Jonathan Chief R&D Officer
NEKTAR THERAPEUTICS · $NKTR
$336K Total Value
5,538 Shares Traded
$60.71 Price / Share
15,437 Shares Owned After
2026-06-17 Filing Date

Transaction Details

InsiderZalevsky Jonathan
TitleChief R&D Officer
CompanyNEKTAR THERAPEUTICS
TickerNKTR
Transaction TypeSale
Transaction Date2026-06-15
Shares Traded5,538
Price Per Share$60.71
Total Value$336K
Filed Date2026-06-17
Accession Number0001193125-26-274534

Ownership Context

Shares Owned After Transaction15,437
Ownership TypeDirect

SEC Filing

↗ View Original SEC Filing

Accession: 0001193125-26-274534

Other Insider Trades — NKTR

Other Trades by Zalevsky Jonathan

Full Ticker Profile

View all insider trades, dark pool activity, congressional filings, and the Whisper Score for NKTR — NEKTAR THERAPEUTICS →

Whisper Score — NKTR

75.35
Frenzy
Current Whisper Score

See full analysis for NKTR →

Track NKTR insider activity in real time on The Wire →

Get alerts when Zalevsky Jonathan files new trades — Go Pro →

Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.

Last updated: June 19, 2026 at 07:01 UTC

Want real-time data? Access The Wire for live sentiment tracking.